Release of biologically active agents from polymeric composite particles

US10111424B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10111424-B2
Application numberUS-201414891560-A
CountryUS
Kind codeB2
Filing dateMay 13, 2014
Priority dateMay 17, 2013
Publication dateOct 30, 2018
Grant dateOct 30, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Polymeric composite particles are provided that can be used for the storage and delivery of various biologically active agent. The polymeric composite particles contain a porous polymeric core and a coating layer around the porous polymeric core. The porous polymeric composite particles typically further include a biologically active agent positioned within the porous polymeric core but not covalently bonded to the porous polymeric core. The biologically active agent can be released from the polymeric composite particle by diffusing out of the porous polymeric core through the coating layer.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymeric composite particle comprising a) a porous polymeric core particle comprising a washed and dried polymerized product of a reaction mixture comprising: i) a first phase comprising either 1) water and a polysaccharide dissolved in the water; or 2) a surfactant and a compound of Formula (I) wherein n is an integer equal to at least 1, or a mixture thereof; and ii) a second phase dispersed in the first phase, wherein a volume of the first phase is greater than a volume of the second phase and wherein the second phase comprises 1) a monomer composition comprising a first monomer of Formula (II) wherein the monomer of Formula (II) is not miscible with the first phase; p is an integer is no greater than 30; R 1 is hydrogen or alkyl; and 2) a poly(propylene glycol) having a weight average molecular weight of at least 500 grams/mole, wherein the poly(propylene glycol) is removed from the polymerized product to provide the porous polymeric core; b) a biologically active agent positioned within the porous polymeric core, wherein the biologically active agent is not covalently bonded to the porous polymeric core; and c) a coating layer around the porous polymeric core particle, wherein the coating layer comprises a thermoplastic polymer, a wax, or a mixture thereof. 2. The polymeric composite particle of claim 1 , wherein the polymeric composite particle has a core-shell configuration with the core being the porous polymeric core particle and the shell being the coating layer. 3. The polymeric composite particle of claim 1 , wherein the first phase comprise water and 10 to 30 weight percent polysaccharide based on a total weight of the first phase. 4. The polymeric composite particle of claim 1 , wherein the first phase comprises the compound of Formula (I) and a nonionic surfactant. 5. The polymeric composite particle of claim 1 , wherein the monomer composition comprises a second monomer of Formula (III) wherein R 1 is hydrogen or methyl; Y is a single bond, alkylene, oxyalkylene, or poly(oxyalkylene); and R 2 is a carbocyclic group or heterocyclic group. 6. The polymeric composite particle of claim 1 , wherein the monomer composition comprises a second monomer of Formula (VII) or a salt thereof wherein R 1 is hydrogen or methyl; and R 6 is an alkylene. 7. The polymeric composite particle of claim 1 , wherein the biologically active agent comprises a herbicide, insecticide, fungicide, or mixture thereof. 8. The polymeric composite particle of claim 1 , wherein the coating layer comprises a silicone-based thermoplastic polymer, (meth)acrylate-based thermoplastic polymer, olefin-based thermoplastic polymer, styrene-based thermoplastic polymer, or a phenoxy-based resin. 9. The polymeric composite particle of claim 1 , wherein the coating layer comprises an animal wax, vegetable wax, petroleum wax, hydrogenate vegetable oil, or polyethylene. 10. The polymeric composite particle of claim 1 , wherein the polymeric composite particle comprises 20 to 90 weight percent porous polymeric core particle, 0.1 to 40 weight percent biologically active agent, and 10 to 80 weight percent coating layer. 11. A method of delivering a biologically active agent, the method comprising: providing a polymeric composite particle comprising a) a porous polymeric core particle comprising a washed and dried polymerized product of a reaction mixture comprising: i) a first phase comprising either 1) water and a polysaccharide dissolved in the water; or 2) a surfactant and a compound of Formula (I) ii) a second phase dispersed in the first phase, wherein a volume of the first phase is greater than a volume of the second phase and wherein the second phase comprises 1) a monomer composition comprising a first monomer of Formula (II) wherein  the monomer of Formula (II) is not miscible with the first phase;  p is an integer is no greater than 30;  R 1 is hydrogen or alkyl; and 2) a poly(propylene glycol) having a weight average molecular weight of at least 500 grams/mole, wherein the poly(propylene glycol) is removed from the polymerized product to provide the porous polymeric core; b) a biologically active agent positioned within the porous polymeric core, wherein the biologically active agent is not covalently bonded to the porous polymeric core; and c) a coating layer around the porous polymeric core particle, wherein the coating layer comprises a thermoplastic polymer, a wax, or a mixture thereof; and releasing the biologically active agent from the polymeric composite particle by diffusion through the coating layer. 12. The method of claim 11 , wherein the first phase comprise water and 10 to 30 weight percent polysaccharide based on a total weight of the first phase. 13. The method of claim 11 , wherein the first phase comprises the compound of Formula (I) and a nonionic surfactant. 14. The method of claim 11 , wherein providing the polymeric composite particle comprises forming the porous polymeric core particle; positioning the biologically active agent within the porous polymeric core particle to form a loaded polymeric particle; and depositing the coating layer around the loaded polymeric particle. 15. The method of claim 14 , wherein depositing the coating layer comprises preparing a coating solution or a coating dispersion; mixing the loaded polymeric particle with the coating solution or coating dispersion to form a slurry; and drying the slurry, wherein drying comprises spray drying or fluidized bed drying.

Assignees

Inventors

Classifications

  • C08J3/126Primary

    Polymer particles coated by polymer, e.g. core shell structures · CPC title

  • A01N25/26Primary

    in coated particulate form · CPC title

  • Drying and spraying · CPC title

  • Organogel, i.e. a gel containing an organic composition · CPC title

  • the liquid phase being a solvent for the monomers but not for the resulting macromolecular composition, i.e. macroporous or macroreticular polymers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10111424B2 cover?
Polymeric composite particles are provided that can be used for the storage and delivery of various biologically active agent. The polymeric composite particles contain a porous polymeric core and a coating layer around the porous polymeric core. The porous polymeric composite particles typically further include a biologically active agent positioned within the porous polymeric core but not cov…
Who is the assignee on this patent?
3M Innovative Properties Co
What technology area does this patent fall under?
Primary CPC classification C08J3/126. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).